Nonsteroidal antiinflammatory drugs and susceptibility to COVID-19

May-21

Pharmacoepidemiology Virology and Immunisations

AUTHORS : Dr Krishnarajah Nirantharakumar, IOEM Building, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK – Email: k.nirantharan@bham.ac.uk – Profile: https://www.birmingham.ac.uk/staff/profiles/applied-health/nirantharakumar-krishnarajah.aspx OR Prof Karim Raza, PhD, Institute of Inflammation and Ageing, College of Medical and Dental Sciences, University of Birmingham, Queen Elizabeth Hospital, Birmingham, B15 2WB, UK – Email: k.raza@bham.ac.uk – Profile: https://www.birmingham.ac.uk/staff/profiles/inflammation-ageing/raza-karim.aspx

JOURNAL : Arthritis & Rheumatology

REFERENCE: 73(5):731-739

DOI : 10.1002/art.41593

Nonsteroidal antiinflammatory drugs and susceptibility to COVID-19

More publications

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Increased risk of fracture among patients with iron overload: a population-based matched cohort study